Marinus Pharmaceuticals, Inc. (MRNS) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the recent downtrend for the company, as the stock is now down almost 10% in the past one-month time frame.
Over the last 30 days, the company witnessed a mixed record of two positive and one negative estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Marinus Pharmaceuticals currently has a Zacks Rank #3 (Hold).
A better-ranked med-drugs stock is Cardiome Pharma Corp. (CRME) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment